Hypoxia, Brain Clinical Trial
Official title:
Effect of Hypotensive Anesthesia on Cerebral Perfusion and Blood Antioxidant Levels and HIF 1a
The aim of this study to evaluate the patients who underwent controlled hypotensive anesthesia under standardized depth of anesthesia; preoperative and postoperative blood HIF 1a, TAS, TOS measurement and cerebral perfusion evaluation with NIRS and to investigate tissue hypoxia secondary to hypotensive anesthesia and the changes of the mediators at the tissue level and which blood pressure parameters are related.
Controlled hypotension is the voluntary reversible reduction of arterial blood pressure.
Hypotensive anesthesia is a method of anesthesia in which blood pressure is reduced in a
controlled manner, especially in certain surgeries. İt reduces intraoperative bleeding and
need for blood transfusion and provides a clean surgical vision in narrow-field surgeries or
with high bleeding potential. Hypotensive anesthesia can be performed according to mean blood
pressure (MBP) or systolic blood pressure (SBP).
A non-invasive cerebral oximeter is used to see the changes in the brain due to high
oxygen-dependent metabolism during induction and maintenance of anesthesia.
Hypoxia inducible factor (HIF) is a transcription factor involved in cell adaptation
mechanism activated in response to hypoxia.
The biological activity of HIF 1 is determined by the expression and activity of the HIF 1a
subunit.
Total antioxidant status (TAS) shows the total effect of all antioxidants in the human body
and total oxidant status (TOS) shows the total effect of oxidants.
Near Infrared Spectroscopy (NIRS) allows continuous and non-invasive monitoring of cerebral
oxygenation. HIF 1a, TAS and TOS are laboratory markers that predict tissue oxygenation and
perfusion.
Hypotensive anesthesia can be performed according to both MBP and SBP. However, in our study
that follow-up MBP is more advantageous/protective, although it is not supported by very
strong data. The investigators recommend hypotensive anesthesia compared to MBP; but further
studies are needed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01192776 -
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A | |
| Completed |
NCT00006516 -
Home Stimulation for Brain-Asphyxiated Infants
|
Phase 2 | |
| Completed |
NCT03268590 -
Neuroimaging During Pure Oxygen Breathing
|
Phase 4 | |
| Completed |
NCT03112486 -
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
|
||
| Completed |
NCT01793129 -
Preemie Hypothermia for Neonatal Encephalopathy
|
N/A | |
| Completed |
NCT03100019 -
Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.
|
N/A | |
| Active, not recruiting |
NCT03145142 -
PREMOD2 With Near Infrared Spectroscopy Sub-study
|
N/A | |
| Completed |
NCT04280744 -
Feasibility of a Music Therapy Intervention to Decrease Stress During Pediatric Critical Care
|
N/A | |
| Recruiting |
NCT05753345 -
Aquatic Therapy for Children With Neuromotor Deficits
|
N/A | |
| Enrolling by invitation |
NCT04258774 -
The Effect of Respiratory Challenge on the BOLD Signal
|
N/A | |
| Completed |
NCT03338907 -
CO2 (Carbon Dioxide) - Cerebral Oxygenation
|
Phase 2 | |
| Completed |
NCT03706651 -
Assessment of Tele-expertise for the Interpretation of MRI Among Neonates With High Risk of Neurological Sequelae
|
||
| Recruiting |
NCT01506258 -
Autologous Stem Cells in Newborns With Oxygen Deprivation
|
N/A | |
| Not yet recruiting |
NCT03255408 -
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
|
Phase 1/Phase 2 | |
| Completed |
NCT04184245 -
Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants
|
||
| Recruiting |
NCT05564754 -
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
|
N/A | |
| Recruiting |
NCT06207942 -
Stepcare Extended Follow-up Substudy
|
N/A | |
| Completed |
NCT00614744 -
Late Hypothermia for Hypoxic-Ischemic Encephalopathy
|
N/A |